196 related articles for article (PubMed ID: 23441155)
1. Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
Fu D; Cong X; Ma Y; Cai H; Cai M; Li D; Lv M; Yuan X; Huang Y; Lv Z
PLoS One; 2013; 8(2):e55727. PubMed ID: 23441155
[TBL] [Abstract][Full Text] [Related]
2. Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis.
Xia Q; Chen ZX; Wang YC; Ma YS; Zhang F; Che W; Fu D; Wang XF
PLoS One; 2012; 7(11):e50107. PubMed ID: 23226241
[TBL] [Abstract][Full Text] [Related]
3. Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case-control study and meta-analysis.
Han X; Cui H; Chen X; Xie W; Chang Y
Arch Gynecol Obstet; 2015 Aug; 292(2):291-8. PubMed ID: 25633883
[TBL] [Abstract][Full Text] [Related]
4. Association of GCK -30G> a polymorphism with gestational diabetes mellitus and type 2 diabetes mellitus risk: a meta-analysis involving 18 case-control studies.
Yang S; Du Q
Genet Test Mol Biomarkers; 2014 May; 18(5):289-98. PubMed ID: 24520939
[TBL] [Abstract][Full Text] [Related]
5. Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis.
Li H; Xu R; Peng X; Wang Y; Wang T
Mol Biol Rep; 2013 Jun; 40(6):3935-42. PubMed ID: 23307301
[TBL] [Abstract][Full Text] [Related]
6. A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites.
Rose CS; Ek J; Urhammer SA; Glümer C; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
Diabetes; 2005 Oct; 54(10):3026-31. PubMed ID: 16186409
[TBL] [Abstract][Full Text] [Related]
7. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Wang H; Liu L; Zhao J; Cui G; Chen C; Ding H; Wang DW
PLoS One; 2013; 8(6):e67665. PubMed ID: 23840762
[TBL] [Abstract][Full Text] [Related]
8. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the effect of KCNJ11 gene polymorphism on the risk of type 2 diabetes.
Qiu L; Na R; Xu R; Wang S; Sheng H; Wu W; Qu Y
PLoS One; 2014; 9(4):e93961. PubMed ID: 24710510
[TBL] [Abstract][Full Text] [Related]
10. The association between KCNQ1 gene polymorphism and type 2 diabetes risk: a meta-analysis.
Sun Q; Song K; Shen X; Cai Y
PLoS One; 2012; 7(11):e48578. PubMed ID: 23133642
[TBL] [Abstract][Full Text] [Related]
11. β-Cell glucokinase expression was increased in type 2 diabetes subjects with better glycemic control.
Liu J; Fu H; Kang F; Ning G; Ni Q; Wang W; Wang Q
J Diabetes; 2023 May; 15(5):409-418. PubMed ID: 36942376
[TBL] [Abstract][Full Text] [Related]
12. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
13. Transcription Factor 7-Like 2 (TCF7L2) rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis.
Lin PC; Lin WT; Yeh YH; Wung SF
PLoS One; 2016; 11(4):e0153044. PubMed ID: 27058589
[TBL] [Abstract][Full Text] [Related]
14. The effect of KCNJ11 polymorphism on the risk of type 2 diabetes: a global meta-analysis based on 49 case-control studies.
Gong B; Yu J; Li H; Li W; Tong X
DNA Cell Biol; 2012 May; 31(5):801-10. PubMed ID: 22082043
[TBL] [Abstract][Full Text] [Related]
15. Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific (1rs8418532).
Du B; Liu S; Cui C; Wang S; Cui W
J Diabetes; 2013 Sep; 5(3):291-9. PubMed ID: 23480298
[TBL] [Abstract][Full Text] [Related]
16. The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.
Wang L; Teng Z; Cai S; Wang D; Zhao X; Yu K
Diagn Pathol; 2013 Jul; 8():118. PubMed ID: 23856170
[TBL] [Abstract][Full Text] [Related]
17. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S; Jin GJ; Zhao Y; Kang H
Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
[TBL] [Abstract][Full Text] [Related]
18. Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.
Chen M; Li S
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988065
[No Abstract] [Full Text] [Related]
19. Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Shi Y; Li Y; Wang J; Wang C; Fan J; Zhao J; Yin L; Liu X; Zhang D; Li L
PLoS One; 2017; 12(7):e0181232. PubMed ID: 28704540
[TBL] [Abstract][Full Text] [Related]
20. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.
Sparsø T; Andersen G; Nielsen T; Burgdorf KS; Gjesing AP; Nielsen AL; Albrechtsen A; Rasmussen SS; Jørgensen T; Borch-Johnsen K; Sandbaek A; Lauritzen T; Madsbad S; Hansen T; Pedersen O
Diabetologia; 2008 Jan; 51(1):70-5. PubMed ID: 18008060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
